Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands;
J Am Soc Nephrol. 2014 Feb;25(2):390-8. doi: 10.1681/ASN.2012121222. Epub 2013 Oct 24.
Treatment goals for patients with CKD are often unrealized for many reasons, but support by nurse practitioners may improve risk factor levels in these patients. Here, we analyzed renal endpoints of the Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of Nurse Practitioners (MASTERPLAN) study after extended follow-up to determine whether strict implementation of current CKD guidelines through the aid of nurse practitioners improves renal outcome. In total, 788 patients with moderate to severe CKD were randomized to receive nurse practitioner support added to physician care (intervention group) or physician care alone (control group). Median follow-up was 5.7 years. Renal outcome was a secondary endpoint of the MASTERPLAN study. We used a composite renal endpoint of death, ESRD, and 50% increase in serum creatinine. Event rates were compared with adjustment for baseline serum creatinine concentration and changes in estimated GFR were determined. During the randomized phase, there were small but significant differences between the groups in BP, proteinuria, LDL cholesterol, and use of aspirin, statins, active vitamin D, and antihypertensive medications, in favor of the intervention group. The intervention reduced the incidence of the composite renal endpoint by 20% (hazard ratio, 0.80; 95% confidence interval, 0.66 to 0.98; P=0.03). In the intervention group, the decrease in estimated GFR was 0.45 ml/min per 1.73 m(2) per year less than in the control group (P=0.01). In conclusion, additional support by nurse practitioners attenuated the decline of kidney function and improved renal outcome in patients with CKD.
治疗慢性肾脏病(CKD)患者的目标往往因多种原因无法实现,但护士从业者的支持可能会改善这些患者的风险因素水平。在这里,我们对多因素方法和护士从业者辅助下的肾患者优越治疗效果(MASTERPLAN)研究的肾脏终点进行了扩展随访分析,以确定通过护士从业者的帮助严格实施当前 CKD 指南是否会改善肾脏预后。共有 788 名中重度 CKD 患者被随机分为接受护士从业者支持的医师护理(干预组)或单独医师护理(对照组)。中位随访时间为 5.7 年。肾脏结局是 MASTERPLAN 研究的次要终点。我们使用死亡、终末期肾病和血清肌酐增加 50%的复合肾脏终点。通过调整基线血清肌酐浓度和估计肾小球滤过率的变化来比较事件发生率。在随机阶段,两组之间的血压、蛋白尿、LDL 胆固醇和阿司匹林、他汀类药物、活性维生素 D 和抗高血压药物的使用存在微小但显著的差异,有利于干预组。干预组复合肾脏终点的发生率降低了 20%(风险比,0.80;95%置信区间,0.66 至 0.98;P=0.03)。在干预组中,估计肾小球滤过率的下降比对照组少 0.45 ml/min/1.73 m²/年(P=0.01)。总之,护士从业者的额外支持减轻了 CKD 患者肾功能的下降并改善了肾脏预后。